Inventor · disambiguated record
David S. F. Young
Also filed as: YOUNG DAVID · YOUNG DAVID S · YOUNG DAVID S F
52 granted patents·72 pending applications·532 citations·filing 1994–2025
98Inventor score
Files withARIUS RES INC49YOUNG DAVID S F42KISOJI BIOTECHNOLOGY INC8HOFFMANN LA ROCHE7MALLINCKRODT ARD IP LTD2
Top patents by PatentIndex Score
124 records- 0197US6180357B1Individualized patient-specific anti-cancer antibodiesARIUS RES INC·Filed 1999·Granted Jan 30, 2001·173 cites·1 claims
- 0296US7420040B2Cytotoxicity mediation of cells evidencing surface expression of TROP-2ARIUS RES INC·Filed 2007·Granted Sep 2, 2008·65 cites·9 claims
- 0395US7420041B2Cytotoxicity mediation of cells evidencing surface expression of TROP-2ARIUS RES INC·Filed 2007·Granted Sep 2, 2008·59 cites·9 claims
- 0495US6657048B2Individualized anti-cancer antibodiesARIUS RES INC·Filed 2000·Granted Dec 2, 2003·56 cites·2 claims
- 0594US7189825B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2004·Granted Mar 13, 2007·24 cites·16 claims
- 0692US7456016B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2007·Granted Nov 25, 2008·11 cites·8 claims
- 0791US7009040B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2003·Granted Mar 7, 2006·16 cites·16 claims
- 0889US7431923B2Cytotoxicity mediation of cells evidencing surface expression of CD63ARIUS RES INC·Filed 2005·Granted Oct 7, 2008·7 cites·6 claims
- 0985US10232018B2ACTH for treatment of acute respiratory distress syndromeMALLINCKRODT ARD IP LTD·Filed 2014·Granted Mar 19, 2019·8 cites·21 claims
- 1084US7442777B2Cytotoxicity mediation of cells evidencing surface expression of CD63ARIUS RES INC·Filed 2006·Granted Oct 28, 2008·6 cites·5 claims
- 1184US7393531B2Cytotoxicity mediation of cells evidencing surface expression of MCSPARIUS RES INC·Filed 2004·Granted Jul 1, 2008·11 cites·10 claims
- 1284US6794494B1Cancerous disease modifying antibodiesARIUS RES INC·Filed 2003·Granted Sep 21, 2004·17 cites·10 claims
- 1383US7507537B2Cytotoxicity mediation of cells evidencing surface expression of CD44HOFFMANN LA ROCHE·Filed 2006·Granted Mar 24, 2009·4 cites·18 claims
- 1483US7252821B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2003·Granted Aug 7, 2007·9 cites·13 claims
- 1582US7411046B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2006·Granted Aug 12, 2008·5 cites·20 claims
- 1682US7189397B2Cytotoxicity mediation of cells evidencing surface expression of CD44ARIUS RES INC·Filed 2003·Granted Mar 13, 2007·11 cites·16 claims
- 1780US12371508B2Binding agents targeting TROP2-expressing tumor cellsKISOJI BIOTECHNOLOGY INC·Filed 2024·Granted Jul 29, 2025·0 cites·28 claims
- 1880US12338295B2Binding agents targeting TROP2-expressing tumor cellsKISOJI BIOTECHNOLOGY INC·Filed 2024·Granted Jun 24, 2025·0 cites·28 claims
- 1980US12275799B2Binding agents targeting TROP2-expressing tumor cellsKISOJI BIOTECHNOLOGY INC·Filed 2024·Granted Apr 15, 2025·0 cites·23 claims
- 2080US7468254B2Cytotoxicity mediation of cells evidencing surface expression of MCSPARIUS RES INC·Filed 2004·Granted Dec 23, 2008·5 cites·4 claims
- 2180US7399835B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2005·Granted Jul 15, 2008·4 cites·17 claims
- 2278US8071072B2Cytotoxicity mediation of cells evidencing surface expression of CD44YOUNG DAVID S F·Filed 2007·Granted Dec 6, 2011·3 cites·10 claims
- 2377US8017117B2Cytotoxicity mediation of cells evidencing surface expression of CD44HOFFMANN LA ROCHE·Filed 2008·Granted Sep 13, 2011·2 cites·8 claims
- 2476US7361342B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2004·Granted Apr 22, 2008·3 cites·5 claims
- 2576US6770262B2Nasal administration of agents for the treatment of gastroparesisQUESTCOR PHARMACEUTICALS INC·Filed 2001·Granted Aug 3, 2004·17 cites·35 claims
- 2676US2024360242A1Binding agents targeting trop2-expressing tumor cellsKISOJI BIOTECHNOLOGY INC·Filed 2024·Application pending·0 cites
- 2773US7947496B2Cytotoxicity mediation of cells evidencing surface expression of CD44HOFFMANN LA ROCHE·Filed 2006·Granted May 24, 2011·1 cites·5 claims
- 2873US2009053215A1Cytotoxicity mediation of cells evidencing surface expression of CD63YOUNG DAVID S F·Filed 2008·Application pending·0 cites
- 2973US2008260635A1Cytotoxicity mediation of cells evidencing surface expression of MCSPYOUNG DAVID S F·Filed 2008·Application pending·0 cites
- 3072US7175846B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2006·Granted Feb 13, 2007·1 cites·8 claims
- 3170US7186808B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2004·Granted Mar 6, 2007·0 cites·16 claims
- 3269US2009074662A1Cancerous Disease modifying antibodiesARIUS RES INC·Filed 2008·Application pending·0 cites
- 3368US7534429B2Cytotoxicity mediation of cells evidencing surface expression of CD63HOFFMANN LA ROCHE·Filed 2006·Granted May 19, 2009·1 cites·16 claims
- 3468US7485300B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2007·Granted Feb 3, 2009·0 cites·36 claims
- 3568US2008213171A1Cancerous disease modifying antibodiesYOUNG DAVID S F·Filed 2008·Application pending·0 cites
- 3667US2008267864A1Cancerous disease modifying antibodiesARIUS RES INC·Filed 2008·Application pending·0 cites
- 3764US7494648B2Cancerous disease modifying antibodiesHOFFMANN LA ROCHE·Filed 2006·Granted Feb 24, 2009·0 cites·16 claims
- 3864US7456258B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2006·Granted Nov 25, 2008·0 cites·20 claims
- 3964US7452978B2Cancerous disease modifying antibodiesARIUS RES INC·Filed 2006·Granted Nov 18, 2008·0 cites·20 claims
- 4064US2005100542A1Cytotoxicity mediation of cells evidencing surface expression of CD44Filed 2004·Application pending·0 cites
- 4163US2009142263A1Cytotoxicity mediation of cells evidencing surface expression of TROP-2ARIUS RES INC·Filed 2008·Application pending·0 cites
- 4263US2009191118A1Cytotoxicity mediation of cells evidencing surface expression of TROP-2ARIUS RES INC·Filed 2008·Application pending·0 cites
- 4361US7442776B2Cancerous disease modifying antibodiesYOUNG DAVID S F·Filed 2004·Granted Oct 28, 2008·3 cites·8 claims
- 4461US7361343B2Cytotoxicity mediation of cells evidencing surface expression of CD63ARIUS RES INC·Filed 2004·Granted Apr 22, 2008·1 cites·10 claims
- 4560US2009068099A1Cancerous disease modifying antibodiesYOUNG DAVID S F·Filed 2008·Application pending·0 cites
- 4660US2025017931A1Methods of personalizing cancer treatmentPROCESSA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4760US2009068182A1Cytotoxicity mediation of cells evidencing surface expression of CD9ARIUS RES INC·Filed 2008·Application pending·0 cites
- 4860US2009068100A1Cancerous disease modifying antibodiesYOUNG DAVID S F·Filed 2008·Application pending·0 cites
- 4959US2008279767A1Cancerous disease modifying antibodiesYOUNG DAVID S F·Filed 2008·Application pending·0 cites
- 5059US2008213169A1Cytotoxicity mediation of cells evidencing surface expression of CD59ARIUS RES INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 124 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David S. F. Young files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →